nodes	percent_of_prediction	percent_of_DWPC	metapath
Naproxen—Breast neoplasm—Octreotide—thymus cancer	0.027	0.028	CcSEcCtD
Naproxen—Breast feeding—Octreotide—thymus cancer	0.0233	0.0242	CcSEcCtD
Naproxen—Prostatic disorder—Octreotide—thymus cancer	0.0192	0.0199	CcSEcCtD
Naproxen—Stomach ache—Octreotide—thymus cancer	0.0192	0.0199	CcSEcCtD
Naproxen—Ulcerative stomatitis—Octreotide—thymus cancer	0.0176	0.0183	CcSEcCtD
Naproxen—Epigastric pain—Octreotide—thymus cancer	0.0168	0.0175	CcSEcCtD
Naproxen—Rectal disorder—Octreotide—thymus cancer	0.0166	0.0172	CcSEcCtD
Naproxen—Appetite absent—Octreotide—thymus cancer	0.0164	0.017	CcSEcCtD
Naproxen—Anorectal disorder—Octreotide—thymus cancer	0.0155	0.0161	CcSEcCtD
Naproxen—Renal pain—Octreotide—thymus cancer	0.0155	0.0161	CcSEcCtD
Naproxen—Ear disorder—Octreotide—thymus cancer	0.0151	0.0157	CcSEcCtD
Naproxen—Cholecystitis—Octreotide—thymus cancer	0.0142	0.0147	CcSEcCtD
Naproxen—Cholelithiasis—Octreotide—thymus cancer	0.0131	0.0136	CcSEcCtD
Naproxen—Nail disorder—Octreotide—thymus cancer	0.0126	0.013	CcSEcCtD
Naproxen—Peptic ulcer—Octreotide—thymus cancer	0.0122	0.0127	CcSEcCtD
Naproxen—Redness—Octreotide—thymus cancer	0.0121	0.0125	CcSEcCtD
Naproxen—Menstrual disorder—Octreotide—thymus cancer	0.0119	0.0124	CcSEcCtD
Naproxen—Neuralgia—Octreotide—thymus cancer	0.0117	0.0122	CcSEcCtD
Naproxen—Influenza-like symptoms—Octreotide—thymus cancer	0.0114	0.0118	CcSEcCtD
Naproxen—Metrorrhagia—Octreotide—thymus cancer	0.0114	0.0118	CcSEcCtD
Naproxen—Throat sore—Octreotide—thymus cancer	0.0113	0.0117	CcSEcCtD
Naproxen—Oropharyngeal discomfort—Octreotide—thymus cancer	0.0112	0.0116	CcSEcCtD
Naproxen—Neuritis—Octreotide—thymus cancer	0.0109	0.0113	CcSEcCtD
Naproxen—Herpes zoster—Octreotide—thymus cancer	0.0108	0.0112	CcSEcCtD
Naproxen—Cholestasis—Octreotide—thymus cancer	0.0107	0.0111	CcSEcCtD
Naproxen—Otitis media—Octreotide—thymus cancer	0.0105	0.0109	CcSEcCtD
Naproxen—Nephrolithiasis—Octreotide—thymus cancer	0.0101	0.0105	CcSEcCtD
Naproxen—Acne—Octreotide—thymus cancer	0.00968	0.0101	CcSEcCtD
Naproxen—Neoplasm malignant—Octreotide—thymus cancer	0.00954	0.00991	CcSEcCtD
Naproxen—Rectal haemorrhage—Octreotide—thymus cancer	0.00902	0.00936	CcSEcCtD
Naproxen—Cellulitis—Octreotide—thymus cancer	0.00896	0.0093	CcSEcCtD
Naproxen—Oropharyngeal pain—Octreotide—thymus cancer	0.00896	0.0093	CcSEcCtD
Naproxen—Arthropathy—Octreotide—thymus cancer	0.00896	0.0093	CcSEcCtD
Naproxen—Herpes simplex—Octreotide—thymus cancer	0.00884	0.00918	CcSEcCtD
Naproxen—Hearing impaired—Octreotide—thymus cancer	0.00855	0.00889	CcSEcCtD
Naproxen—Vaginal inflammation—Octreotide—thymus cancer	0.00814	0.00846	CcSEcCtD
Naproxen—Eructation—Octreotide—thymus cancer	0.008	0.00831	CcSEcCtD
Naproxen—Hyperkalaemia—Octreotide—thymus cancer	0.008	0.00831	CcSEcCtD
Naproxen—Cystitis noninfective—Octreotide—thymus cancer	0.00795	0.00826	CcSEcCtD
Naproxen—Wheezing—Octreotide—thymus cancer	0.00791	0.00821	CcSEcCtD
Naproxen—Influenza like illness—Octreotide—thymus cancer	0.00791	0.00821	CcSEcCtD
Naproxen—Cystitis—Octreotide—thymus cancer	0.00786	0.00817	CcSEcCtD
Naproxen—Vaginal infection—Octreotide—thymus cancer	0.00769	0.00799	CcSEcCtD
Naproxen—Bladder pain—Octreotide—thymus cancer	0.00736	0.00765	CcSEcCtD
Naproxen—Urine output increased—Octreotide—thymus cancer	0.00736	0.00765	CcSEcCtD
Naproxen—Mouth ulceration—Octreotide—thymus cancer	0.00736	0.00765	CcSEcCtD
Naproxen—Thrombophlebitis—Octreotide—thymus cancer	0.00683	0.00709	CcSEcCtD
Naproxen—Diabetes mellitus—Octreotide—thymus cancer	0.0068	0.00706	CcSEcCtD
Naproxen—Polyuria—Octreotide—thymus cancer	0.00673	0.00699	CcSEcCtD
Naproxen—Gastroenteritis—Octreotide—thymus cancer	0.00667	0.00693	CcSEcCtD
Naproxen—Deafness—Octreotide—thymus cancer	0.00661	0.00686	CcSEcCtD
Naproxen—Cardiac failure congestive—Octreotide—thymus cancer	0.00652	0.00677	CcSEcCtD
Naproxen—Amnesia—Octreotide—thymus cancer	0.00629	0.00653	CcSEcCtD
Naproxen—Visual disturbance—Octreotide—thymus cancer	0.00624	0.00648	CcSEcCtD
Naproxen—Anaphylactoid reaction—Octreotide—thymus cancer	0.00611	0.00634	CcSEcCtD
Naproxen—Hypoglycaemia—Octreotide—thymus cancer	0.00606	0.00629	CcSEcCtD
Naproxen—Osteoarthritis—Octreotide—thymus cancer	0.00591	0.00614	CcSEcCtD
Naproxen—Gastrointestinal haemorrhage—Octreotide—thymus cancer	0.00591	0.00614	CcSEcCtD
Naproxen—Dehydration—Octreotide—thymus cancer	0.0055	0.00571	CcSEcCtD
Naproxen—Dry skin—Octreotide—thymus cancer	0.00542	0.00563	CcSEcCtD
Naproxen—Abdominal pain upper—Octreotide—thymus cancer	0.0054	0.00561	CcSEcCtD
Naproxen—Cramp muscle—Octreotide—thymus cancer	0.00532	0.00553	CcSEcCtD
Naproxen—Gastritis—Octreotide—thymus cancer	0.00523	0.00543	CcSEcCtD
Naproxen—Muscular weakness—Octreotide—thymus cancer	0.00521	0.00542	CcSEcCtD
Naproxen—Abdominal distension—Octreotide—thymus cancer	0.00514	0.00534	CcSEcCtD
Naproxen—Influenza—Octreotide—thymus cancer	0.00511	0.00531	CcSEcCtD
Naproxen—Asthma—Octreotide—thymus cancer	0.00511	0.00531	CcSEcCtD
Naproxen—Pancreatitis—Octreotide—thymus cancer	0.00501	0.0052	CcSEcCtD
Naproxen—Bronchitis—Octreotide—thymus cancer	0.00491	0.0051	CcSEcCtD
Naproxen—Abdominal discomfort—Octreotide—thymus cancer	0.0049	0.00509	CcSEcCtD
Naproxen—Dysuria—Octreotide—thymus cancer	0.00478	0.00496	CcSEcCtD
Naproxen—Pollakiuria—Octreotide—thymus cancer	0.00472	0.0049	CcSEcCtD
Naproxen—Weight decreased—Octreotide—thymus cancer	0.00462	0.0048	CcSEcCtD
Naproxen—Hyperglycaemia—Octreotide—thymus cancer	0.00461	0.00479	CcSEcCtD
Naproxen—Pneumonia—Octreotide—thymus cancer	0.00458	0.00476	CcSEcCtD
Naproxen—Drowsiness—Octreotide—thymus cancer	0.00456	0.00473	CcSEcCtD
Naproxen—Depression—Octreotide—thymus cancer	0.00454	0.00472	CcSEcCtD
Naproxen—Neuropathy peripheral—Octreotide—thymus cancer	0.00447	0.00464	CcSEcCtD
Naproxen—Jaundice—Octreotide—thymus cancer	0.00444	0.00461	CcSEcCtD
Naproxen—Urinary tract infection—Octreotide—thymus cancer	0.00443	0.0046	CcSEcCtD
Naproxen—Conjunctivitis—Octreotide—thymus cancer	0.00443	0.0046	CcSEcCtD
Naproxen—Haematuria—Octreotide—thymus cancer	0.00434	0.00451	CcSEcCtD
Naproxen—Hepatobiliary disease—Octreotide—thymus cancer	0.00431	0.00447	CcSEcCtD
Naproxen—Epistaxis—Octreotide—thymus cancer	0.0043	0.00446	CcSEcCtD
Naproxen—Sinusitis—Octreotide—thymus cancer	0.00427	0.00444	CcSEcCtD
Naproxen—Rhinitis—Octreotide—thymus cancer	0.0041	0.00426	CcSEcCtD
Naproxen—Hepatitis—Octreotide—thymus cancer	0.00409	0.00425	CcSEcCtD
Naproxen—Pharyngitis—Octreotide—thymus cancer	0.00406	0.00422	CcSEcCtD
Naproxen—Oedema peripheral—Octreotide—thymus cancer	0.00403	0.00418	CcSEcCtD
Naproxen—Visual impairment—Octreotide—thymus cancer	0.00394	0.00409	CcSEcCtD
Naproxen—Tinnitus—Octreotide—thymus cancer	0.00381	0.00396	CcSEcCtD
Naproxen—Cardiac disorder—Octreotide—thymus cancer	0.0038	0.00394	CcSEcCtD
Naproxen—Immune system disorder—Octreotide—thymus cancer	0.00369	0.00384	CcSEcCtD
Naproxen—Arrhythmia—Octreotide—thymus cancer	0.00365	0.00379	CcSEcCtD
Naproxen—Alopecia—Octreotide—thymus cancer	0.00361	0.00375	CcSEcCtD
Naproxen—Mental disorder—Octreotide—thymus cancer	0.00358	0.00372	CcSEcCtD
Naproxen—Erythema—Octreotide—thymus cancer	0.00356	0.0037	CcSEcCtD
Naproxen—Malnutrition—Octreotide—thymus cancer	0.00356	0.0037	CcSEcCtD
Naproxen—Flatulence—Octreotide—thymus cancer	0.00351	0.00364	CcSEcCtD
Naproxen—Tension—Octreotide—thymus cancer	0.00349	0.00363	CcSEcCtD
Naproxen—Nervousness—Octreotide—thymus cancer	0.00346	0.00359	CcSEcCtD
Naproxen—Muscle spasms—Octreotide—thymus cancer	0.00342	0.00355	CcSEcCtD
Naproxen—Vision blurred—Octreotide—thymus cancer	0.00335	0.00348	CcSEcCtD
Naproxen—Tremor—Octreotide—thymus cancer	0.00334	0.00346	CcSEcCtD
Naproxen—Ill-defined disorder—Octreotide—thymus cancer	0.0033	0.00343	CcSEcCtD
Naproxen—Anaemia—Octreotide—thymus cancer	0.00329	0.00342	CcSEcCtD
Naproxen—Malaise—Octreotide—thymus cancer	0.00321	0.00333	CcSEcCtD
Naproxen—Vertigo—Octreotide—thymus cancer	0.0032	0.00332	CcSEcCtD
Naproxen—Syncope—Octreotide—thymus cancer	0.00319	0.00332	CcSEcCtD
Naproxen—Palpitations—Octreotide—thymus cancer	0.00315	0.00327	CcSEcCtD
Naproxen—Loss of consciousness—Octreotide—thymus cancer	0.00313	0.00325	CcSEcCtD
Naproxen—Cough—Octreotide—thymus cancer	0.00311	0.00323	CcSEcCtD
Naproxen—Convulsion—Octreotide—thymus cancer	0.00308	0.0032	CcSEcCtD
Naproxen—Hypertension—Octreotide—thymus cancer	0.00307	0.00319	CcSEcCtD
Naproxen—Myalgia—Octreotide—thymus cancer	0.00303	0.00315	CcSEcCtD
Naproxen—Arthralgia—Octreotide—thymus cancer	0.00303	0.00315	CcSEcCtD
Naproxen—Chest pain—Octreotide—thymus cancer	0.00303	0.00315	CcSEcCtD
Naproxen—Anxiety—Octreotide—thymus cancer	0.00302	0.00314	CcSEcCtD
Naproxen—Unspecified disorder of skin and subcutaneous tissue—Octreotide—thymus cancer	0.00301	0.00313	CcSEcCtD
Naproxen—UGT1A1—hematopoietic system—thymus cancer	0.003	0.0807	CbGeAlD
Naproxen—Discomfort—Octreotide—thymus cancer	0.00299	0.00311	CcSEcCtD
Naproxen—Dry mouth—Octreotide—thymus cancer	0.00296	0.00308	CcSEcCtD
Naproxen—Oedema—Octreotide—thymus cancer	0.00291	0.00302	CcSEcCtD
Naproxen—Anaphylactic shock—Octreotide—thymus cancer	0.00291	0.00302	CcSEcCtD
Naproxen—Infection—Octreotide—thymus cancer	0.00289	0.003	CcSEcCtD
Naproxen—Shock—Octreotide—thymus cancer	0.00286	0.00297	CcSEcCtD
Naproxen—Nervous system disorder—Octreotide—thymus cancer	0.00285	0.00296	CcSEcCtD
Naproxen—Thrombocytopenia—Octreotide—thymus cancer	0.00284	0.00295	CcSEcCtD
Naproxen—Tachycardia—Octreotide—thymus cancer	0.00284	0.00295	CcSEcCtD
Naproxen—Skin disorder—Octreotide—thymus cancer	0.00282	0.00293	CcSEcCtD
Naproxen—Hyperhidrosis—Octreotide—thymus cancer	0.00281	0.00292	CcSEcCtD
Naproxen—Anorexia—Octreotide—thymus cancer	0.00277	0.00288	CcSEcCtD
Naproxen—Musculoskeletal discomfort—Octreotide—thymus cancer	0.00265	0.00275	CcSEcCtD
Naproxen—Insomnia—Octreotide—thymus cancer	0.00263	0.00273	CcSEcCtD
Naproxen—Paraesthesia—Octreotide—thymus cancer	0.00261	0.00271	CcSEcCtD
Naproxen—Dyspnoea—Octreotide—thymus cancer	0.00259	0.00269	CcSEcCtD
Naproxen—Somnolence—Octreotide—thymus cancer	0.00258	0.00268	CcSEcCtD
Naproxen—Dyspepsia—Octreotide—thymus cancer	0.00256	0.00266	CcSEcCtD
Naproxen—Decreased appetite—Octreotide—thymus cancer	0.00253	0.00262	CcSEcCtD
Naproxen—Gastrointestinal disorder—Octreotide—thymus cancer	0.00251	0.00261	CcSEcCtD
Naproxen—Fatigue—Octreotide—thymus cancer	0.0025	0.0026	CcSEcCtD
Naproxen—Constipation—Octreotide—thymus cancer	0.00248	0.00258	CcSEcCtD
Naproxen—Pain—Octreotide—thymus cancer	0.00248	0.00258	CcSEcCtD
Naproxen—AKR1C3—cardiac atrium—thymus cancer	0.00247	0.0664	CbGeAlD
Naproxen—AKR1C3—pituitary gland—thymus cancer	0.00242	0.0649	CbGeAlD
Naproxen—Feeling abnormal—Octreotide—thymus cancer	0.00239	0.00249	CcSEcCtD
Naproxen—Gastrointestinal pain—Octreotide—thymus cancer	0.00238	0.00247	CcSEcCtD
Naproxen—Urticaria—Octreotide—thymus cancer	0.00231	0.0024	CcSEcCtD
Naproxen—Abdominal pain—Octreotide—thymus cancer	0.0023	0.00239	CcSEcCtD
Naproxen—Body temperature increased—Octreotide—thymus cancer	0.0023	0.00239	CcSEcCtD
Naproxen—Hypersensitivity—Octreotide—thymus cancer	0.00214	0.00222	CcSEcCtD
Naproxen—AKR1C3—bone marrow—thymus cancer	0.00209	0.0561	CbGeAlD
Naproxen—Asthenia—Octreotide—thymus cancer	0.00208	0.00217	CcSEcCtD
Naproxen—AKR1C3—thyroid gland—thymus cancer	0.00208	0.0559	CbGeAlD
Naproxen—Pruritus—Octreotide—thymus cancer	0.00206	0.00213	CcSEcCtD
Naproxen—SLCO1A2—hematopoietic system—thymus cancer	0.00203	0.0546	CbGeAlD
Naproxen—Diarrhoea—Octreotide—thymus cancer	0.00199	0.00206	CcSEcCtD
Naproxen—Dizziness—Octreotide—thymus cancer	0.00192	0.002	CcSEcCtD
Naproxen—AKR1C3—lung—thymus cancer	0.00189	0.0508	CbGeAlD
Naproxen—Vomiting—Octreotide—thymus cancer	0.00185	0.00192	CcSEcCtD
Naproxen—Rash—Octreotide—thymus cancer	0.00183	0.0019	CcSEcCtD
Naproxen—Dermatitis—Octreotide—thymus cancer	0.00183	0.0019	CcSEcCtD
Naproxen—Headache—Octreotide—thymus cancer	0.00182	0.00189	CcSEcCtD
Naproxen—Nausea—Octreotide—thymus cancer	0.00173	0.00179	CcSEcCtD
Naproxen—CYP2C8—hematopoietic system—thymus cancer	0.00142	0.0382	CbGeAlD
Naproxen—CYP1A2—hematopoietic system—thymus cancer	0.00133	0.0357	CbGeAlD
Naproxen—AKR1C3—lymph node—thymus cancer	0.00129	0.0347	CbGeAlD
Naproxen—CYP2C9—hematopoietic system—thymus cancer	0.00126	0.0339	CbGeAlD
Naproxen—SLCO1A2—lung—thymus cancer	0.00118	0.0317	CbGeAlD
Naproxen—PTGS1—hematopoietic system—thymus cancer	0.00115	0.031	CbGeAlD
Naproxen—PTGS2—hematopoietic system—thymus cancer	0.0011	0.0296	CbGeAlD
Naproxen—CYP2C8—pituitary gland—thymus cancer	0.00105	0.0283	CbGeAlD
Naproxen—PTGS1—epithelium—thymus cancer	0.00105	0.0283	CbGeAlD
Naproxen—PTGS2—epithelium—thymus cancer	0.00101	0.027	CbGeAlD
Naproxen—PTGS1—cardiac atrium—thymus cancer	0.000875	0.0235	CbGeAlD
Naproxen—PTGS1—pituitary gland—thymus cancer	0.000855	0.023	CbGeAlD
Naproxen—CYP1A2—thyroid gland—thymus cancer	0.00085	0.0228	CbGeAlD
Naproxen—PTGS2—pituitary gland—thymus cancer	0.000817	0.0219	CbGeAlD
Naproxen—ALB—lymph node—thymus cancer	0.000803	0.0216	CbGeAlD
Naproxen—PTGS2—lymphoid tissue—thymus cancer	0.000775	0.0208	CbGeAlD
Naproxen—CYP1A2—lung—thymus cancer	0.000772	0.0207	CbGeAlD
Naproxen—PTGS1—thyroid gland—thymus cancer	0.000737	0.0198	CbGeAlD
Naproxen—PTGS2—bone marrow—thymus cancer	0.000706	0.019	CbGeAlD
Naproxen—PTGS1—lung—thymus cancer	0.000669	0.018	CbGeAlD
Naproxen—PTGS2—lung—thymus cancer	0.00064	0.0172	CbGeAlD
Naproxen—PTGS1—lymph node—thymus cancer	0.000458	0.0123	CbGeAlD
Naproxen—PTGS2—lymph node—thymus cancer	0.000437	0.0118	CbGeAlD
